Clinical trial
Expanded Access of Sotorasib
NCT04667234
Study timeline
Registry last updated2026-08-20
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Non Small-cell Lung Cancerunresolved
Locally Advanced Unresectable NSCLCunresolved
Locally Advanced Metastatic NSCLCunresolved
Interventions
AMG 510DRUG
Sponsors & collaborators
Amgenlead sponsor
Mapped research locations
Petah TikvaIsrael2BostonMassachusetts, United States1PhiladelphiaPennsylvania, United States1ClevelandOhio, United States1OmahaNebraska, United States1TucsonArizona, United States1Winston-SalemNorth Carolina, United States1MemphisTennessee, United States1LexingtonKentucky, United States1Kansas CityMissouri, United States1Baton RougeLouisiana, United States1ChattanoogaTennessee, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT04667234 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.